← runs
HON
HONEYWELL INTERNATIONAL INCeval runfigures
| field | value | statement row | printed | SEC |
|---|---|---|---|---|
| Total revenue | $37.4B | R5 Net sales | 37,442 millions | $37.4B ✓ |
| Operating income | - | not printed on this statement | - | $8.1B |
| Net income attributable to the company | $4.7B | R23 Net income attributable to Honeywell | 4,729 millions | $4.7B ✓ |
| Diluted EPS | $7.36 | R31 Total earnings per share of common stock-assuming dilution | 7.36 | $7.36 ✓ |
| Cash and cash equivalents | $12.5B | R5 Cash and cash equivalents | 12,487 millions | $12.5B ✓ |
| Total assets | $73.7B | R20 Total assets | 73,681 millions | $73.7B ✓ |
| Total liabilities | - | not printed on this statement | - | - |
| Total shareholders' equity attributable to the company | $13.9B | R43 Total Honeywell shareowners’ equity | 13,904 millions | $13.9B ✓ |
| Net cash from operating activities | $6.4B | R32 Net cash provided by operating activities | 6,408 millions | $6.4B ✓ |
| Net cash from investing activities | -$2.7B | R43 Net cash used for investing activities | (2,711) millions | -$2.7B ✓ |
| Net cash from financing activities | -$2.0B | R58 Net cash (used for) provided by financing activities | (1,953) millions | -$2.0B ✓ |
checks
- assets = liabilities + equity · total assets equals total liabilities and equity
- equity excludes minority interests · totalEquity excludes noncontrolling interests
- net income is before preferred dividends · net income is not the after-preferred-dividends line
- diluted EPS is for total net income · diluted EPS is for total net income
- net income excludes minority interests · netIncome excludes noncontrolling interests
- cash flows tie to the change in cash · operating + investing + financing (+ FX) equals the net change in cash
management's claims
The one checkable claim in management's discussion matches the statements. 3 more were about segments, regions or adjusted measures and weren't checked.
- matchesNet cash from operating activities: "Net cash provided by operating activities from continuing operations" changed by 963000000
“Net cash provided by operating activities from continuing operations increased by $963 million, driven by the receipt of the Resideo indemnification and reimbursement agreement termination payment of $1,590 million and $771 million increase in other operating activities, primarily due to a favorable impact of customer advances and deferred revenue, partially offset by the asbestos liabilities divestiture payment of $1,428 million.”
trace
0locator (code)0.23s
{ "tables": 293, "exhibits": [], "documents": 1 }{ "income": { "rows": 32, "scale": 1000000, "score": 51.75, "heading": "F CONTENTS FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA HONEYWELL INTERNATIONAL INC. CONSOLIDATED STATEMENT OF OPERATIONS", "tableIndex": 113, "runnerUpScore": 33 }, "balance": { "rows": 47, "scale": 1000000, "score": 55, "heading": "TABLE OF CONTENTS FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA HONEYWELL INTERNATIONAL INC. CONSOLIDATED BALANCE SHEET", "tableIndex": 117, "runnerUpScore": 24.75 }, "cashflow": { "rows": 63, "scale": 1000000, "score": 55, "heading": "F CONTENTS FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA HONEYWELL INTERNATIONAL INC. CONSOLIDATED STATEMENT OF CASH FLOWS", "tableIndex": 119, "runnerUpScore": 10 } }1cash flow agent1.78s · 1933 tokens · $0.0002
{ "rows": 63, "retryHint": null, "tableIndex": 119 }{ "figures": [ { "note": "This is the total operating cash flow, including continuing and discontinued operations.", "field": "operatingCashFlow", "scale": 1000000, "value": 6408000000, "printed": "6,408", "rowIndex": 32, "rowLabel": "Net cash provided by operating activities", "priorValue": 6097000000, "agentPrinted": "6,408", "failedChecks": [], "priorPrinted": "6,097", "groundingMismatch": false }, { "note": "This is the investing activities section total, including continuing and discontinued operations.", "field": "investingCashFlow", "scale": 1000000, "value": -2711000000, "printed": "(2,711)", "rowIndex": 43, "rowLabel": "Net cash used for investing activities", "priorValue": -10157000000, "agentPrinted": "(2,711)", "failedChecks": [], "priorPrinted": "(10,157)", "groundingMismatch": false }, { "note": "This is the financing activities section total.", "field": "financingCashFlow", "scale": 1000000, "value": -1953000000, "printed": "(1,953)", "rowIndex": 58, "rowLabel": "Net cash (used for) provided by financing activities", "priorValue": 6839000000, "agentPrinted": "(1,953)", "failedChecks": [], "priorPrinted": "6,839", "groundingMismatch": false } ], "statement": "cashflow", "tableIndex": 119, "priorColumn": 1, "currentColumn": 0 }2income statement agent2.12s · 1671 tokens · $0.0002
{ "rows": 32, "retryHint": null, "tableIndex": 113 }{ "figures": [ { "note": "Net sales is the company-wide revenue total, excluding other income.", "field": "revenue", "scale": 1000000, "value": 37442000000, "printed": "37,442", "rowIndex": 5, "rowLabel": "Net sales", "priorValue": 34717000000, "agentPrinted": "37,442", "failedChecks": [], "priorPrinted": "34,717", "groundingMismatch": false }, { "note": "The statement does not print an operating income or equivalent line.", "field": "operatingIncome", "scale": 1000000, "value": null, "printed": null, "rowIndex": null, "rowLabel": null, "priorValue": null, "agentPrinted": null, "failedChecks": [], "priorPrinted": null, "groundingMismatch": false }, { "note": "This is net income attributable to Honeywell, excluding noncontrolling interests.", "field": "netIncome", "scale": 1000000, "value": 4729000000, "printed": "4,729", "rowIndex": 23, "rowLabel": "Net income attributable to Honeywell", "priorValue": 5705000000, "agentPrinted": "4,729", "failedChecks": [], "priorPrinted": "5,705", "groundingMismatch": false }, { "note": "This is total diluted earnings per share, including continuing and discontinued operations.", "field": "epsDiluted", "scale": 1, "value": 7.36, "printed": "7.36", "rowIndex": 31, "rowLabel": "Total earnings per share of common stock-assuming dilution", "priorValue": 8.71, "agentPrinted": "7.36", "failedChecks": [], "priorPrinted": "8.71", "groundingMismatch": false } ], "statement": "income", "tableIndex": 113, "priorColumn": 1, "currentColumn": 0 }3balance sheet agent2.20s · 1508 tokens · $0.0002
{ "rows": 47, "retryHint": null, "tableIndex": 117 }{ "figures": [ { "note": "This is the balance-sheet cash and cash equivalents line.", "field": "cash", "scale": 1000000, "value": 12487000000, "printed": "12,487", "rowIndex": 5, "rowLabel": "Cash and cash equivalents", "priorValue": 9906000000, "agentPrinted": "12,487", "failedChecks": [], "priorPrinted": "9,906", "groundingMismatch": false }, { "note": "This row prints total assets.", "field": "totalAssets", "scale": 1000000, "value": 73681000000, "printed": "73,681", "rowIndex": 20, "rowLabel": "Total assets", "priorValue": 75196000000, "agentPrinted": "73,681", "failedChecks": [], "priorPrinted": "75,196", "groundingMismatch": false }, { "note": "The statement has no total liabilities line; the combined liabilities and equity total is not a substitute.", "field": "totalLiabilities", "scale": 1000000, "value": null, "printed": null, "rowIndex": null, "rowLabel": null, "priorValue": null, "agentPrinted": null, "failedChecks": [], "priorPrinted": null, "groundingMismatch": false }, { "note": "This is total Honeywell shareowners’ equity, excluding noncontrolling interest.", "field": "totalEquity", "scale": 1000000, "value": 13904000000, "printed": "13,904", "rowIndex": 43, "rowLabel": "Total Honeywell shareowners’ equity", "priorValue": 18619000000, "agentPrinted": "13,904", "failedChecks": [], "priorPrinted": "18,619", "groundingMismatch": false } ], "statement": "balance", "tableIndex": 117, "priorColumn": 1, "currentColumn": 0 }4reconciler (code)0.00s
null
[ { "name": "balance_identity", "detail": "total assets equals total liabilities and equity", "fields": [ "totalAssets" ], "passed": true, "skipped": false, "statement": "balance" }, { "name": "totalEquity_attribution", "detail": "totalEquity excludes noncontrolling interests", "fields": [ "totalEquity" ], "passed": true, "skipped": false, "statement": "balance" }, { "name": "netIncome_before_preferred", "detail": "net income is not the after-preferred-dividends line", "fields": [ "netIncome" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "epsDiluted_total", "detail": "diluted EPS is for total net income", "fields": [ "epsDiluted" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "netIncome_attribution", "detail": "netIncome excludes noncontrolling interests", "fields": [ "netIncome" ], "passed": true, "skipped": false, "statement": "income" }, { "name": "cash_flow_tie", "detail": "operating + investing + financing (+ FX) equals the net change in cash", "fields": [ "operatingCashFlow", "investingCashFlow", "financingCashFlow" ], "passed": true, "skipped": false, "statement": "cashflow" } ]5MD&A claims agent3.18s · 1600 tokens · $0.0003
null
[ { "kind": "percent_change", "field": "revenue", "quote": "Leveraging our Honeywell Accelerator operating model, we continued our portfolio transformation, demonstrating growth and operational performance while remaining focused on creating long-term shareowner value. In 2025, we delivered sales growth of 8% to $37.4 billion, with increases in three of our four reportable business segments, led by double-digit growth in our Aerospace Technologies business segment for its third consecutive year.", "scope": "consolidated", "actual": null, "reason": "Total revenue: the sentence is about a region, segment or adjusted measure", "claimed": null, "verdict": "not_checked", "asWritten": "8%", "tolerance": null, "quoteVerified": true }, { "kind": "current_value", "field": "revenue", "quote": "Leveraging our Honeywell Accelerator operating model, we continued our portfolio transformation, demonstrating growth and operational performance while remaining focused on creating long-term shareowner value. In 2025, we delivered sales growth of 8% to $37.4 billion, with increases in three of our four reportable business segments, led by double-digit growth in our Aerospace Technologies business segment for its third consecutive year.", "scope": "consolidated", "actual": null, "reason": "Total revenue: the sentence is about a region, segment or adjusted measure", "claimed": null, "verdict": "not_checked", "asWritten": "$37.4 billion", "tolerance": null, "quoteVerified": true }, { "kind": "amount_change", "field": "operatingCashFlow", "quote": "Net cash provided by operating activities from continuing operations increased by $963 million, driven by the receipt of the Resideo indemnification and reimbursement agreement termination payment of $1,590 million and $771 million increase in other operating activities, primarily due to a favorable impact of customer advances and deferred revenue, partially offset by the asbestos liabilities divestiture payment of $1,428 million.", "scope": "consolidated", "actual": 963000000, "reason": "Net cash from operating activities: \"Net cash provided by operating activities from continuing operations\" changed by 963000000", "claimed": 963000000, "verdict": "consistent", "asWritten": "$963 million", "tolerance": 500000, "quoteVerified": true }, { "kind": "amount_change", "field": "operatingCashFlow", "quote": "Net cash provided by operating activities from continuing operations increased by $653 million, primarily due to the $1,325 million payment made by the Company pursuant to the NARCO Amended Buyout Agreement in 2023, partially offset by $727 million decrease of noncash adjustments, driven by $605 million decline in repositioning and other charges.", "scope": "consolidated", "actual": null, "reason": "Net cash from operating activities: the sentence is about an earlier year", "claimed": null, "verdict": "not_checked", "asWritten": "$653 million", "tolerance": null, "quoteVerified": true } ]
Income statement
table #113 · current period is figure column 1| 0 | Years Ended December 31, | |||
| 1 | 2025 | 2024 | 2023 | |
| 2 | (Dollars in millions,except per share amounts) | |||
| 3 | Product sales | 24,515 | 22,841 | 22,345 |
| 4 | Service sales | 12,927 | 11,876 | 10,664 |
| 5 | Net sales← Total revenue | 37,442 | 34,717 | 33,009 |
| 6 | Costs, expenses and other | |||
| 7 | Cost of products sold | 16,153 | 15,017 | 14,836 |
| 8 | Cost of services sold | 7,460 | 6,343 | 5,801 |
| 9 | Total Cost of products and services sold | 23,613 | 21,360 | 20,637 |
| 10 | Research and development expenses | 1,812 | 1,454 | 1,375 |
| 11 | Selling, general and administrative expenses | 5,450 | 5,235 | 4,887 |
| 12 | Impairment of goodwill | 724 | - | - |
| 13 | Impairment of assets held for sale | 270 | 219 | - |
| 14 | Other (income) expense | (1,247) | (843) | (830) |
| 15 | Interest and other financial charges | 1,344 | 1,048 | 749 |
| 16 | Total costs, expenses and other | 31,966 | 28,473 | 26,818 |
| 17 | Income from continuing operations before taxes | 5,476 | 6,244 | 6,191 |
| 18 | Tax expense | 1,008 | 1,249 | 1,262 |
| 19 | Net income from continuing operations | 4,468 | 4,995 | 4,929 |
| 20 | Net income from discontinued operations | 304 | 745 | 743 |
| 21 | Net income | 4,772 | 5,740 | 5,672 |
| 22 | Less: Net income attributable to noncontrolling interest | 43 | 35 | 14 |
| 23 | Net income attributable to Honeywell← Net income attributable to the company | 4,729 | 5,705 | 5,658 |
| 24 | Earnings per share of common stock-basic: | |||
| 25 | Earnings per share of common stock from continuing operations-basic | 6.98 | 7.63 | 7.41 |
| 26 | Earnings per share of common stock from discontinued operations-basic | 0.42 | 1.13 | 1.12 |
| 27 | Total earnings per share of common stock-basic | 7.40 | 8.76 | 8.53 |
| 28 | Earnings per share of common stock-assuming dilution: | |||
| 29 | Earnings per share of common stock from continuing operations-assuming dilution | 6.94 | 7.58 | 7.36 |
| 30 | Earnings per share of common stock from discontinued operations-assuming dilution | 0.42 | 1.13 | 1.11 |
| 31 | Total earnings per share of common stock-assuming dilution← Diluted EPS | 7.36 | 8.71 | 8.47 |
Balance sheet
table #117 · current period is figure column 1| 0 | December 31, | ||
| 1 | 2025 | 2024 | |
| 2 | (Dollars in millions) | ||
| 3 | ASSETS | ||
| 4 | Current assets | ||
| 5 | Cash and cash equivalents← Cash and cash equivalents | 12,487 | 9,906 |
| 6 | Short-term investments | 443 | 386 |
| 7 | Accounts receivable, less allowances of $202 and $307, respectively | 7,621 | 7,247 |
| 8 | Inventories | 6,162 | 5,884 |
| 9 | Assets held for sale | 2,492 | 1,365 |
| 10 | Other current assets | 1,182 | 1,259 |
| 11 | Current assets of discontinued operations | - | 1,861 |
| 12 | Total current assets | 30,387 | 27,908 |
| 13 | Investments and long-term receivables | 1,404 | 1,230 |
| 14 | Property, plant and equipment-net | 4,629 | 4,457 |
| 15 | Goodwill | 21,079 | 21,019 |
| 16 | Other intangible assets-net | 6,736 | 6,621 |
| 17 | Deferred income taxes | 199 | 235 |
| 18 | Other assets | 9,247 | 10,556 |
| 19 | Assets of discontinued operations | - | 3,170 |
| 20 | Total assets← Total assets | 73,681 | 75,196 |
| 21 | LIABILITIES | ||
| 22 | Current liabilities | ||
| 23 | Accounts payable | 6,315 | 6,109 |
| 24 | Commercial paper and other short-term borrowings | 5,893 | 4,273 |
| 25 | Current maturities of long-term debt | 1,546 | 1,325 |
| 26 | Accrued liabilities | 8,462 | 8,055 |
| 27 | Current liabilities of discontinued operations | - | 1,086 |
| 28 | Liabilities held for sale | 1,198 | 408 |
| 29 | Total current liabilities | 23,414 | 21,256 |
| 30 | Long-term debt | 27,141 | 25,440 |
| 31 | Deferred income taxes | 1,577 | 1,581 |
| 32 | Postretirement benefit obligations other than pensions | 111 | 112 |
| 33 | Asbestos-related liabilities | - | 1,325 |
| 34 | Other liabilities | 6,408 | 5,581 |
| 35 | Liabilities of discontinued operations | - | 740 |
| 36 | Redeemable noncontrolling interest | - | 7 |
| 37 | SHAREOWNERS’ EQUITY | ||
| 38 | Capital-common stock issued | 958 | 958 |
| 39 | -additional paid-in capital | 10,157 | 9,695 |
| 40 | Common stock held in treasury, at cost | (43,029) | (39,378) |
| 41 | Accumulated other comprehensive loss | (5,146) | (3,491) |
| 42 | Retained earnings | 50,964 | 50,835 |
| 43 | Total Honeywell shareowners’ equity← Total shareholders' equity attributable to the company | 13,904 | 18,619 |
| 44 | Noncontrolling interest | 1,126 | 535 |
| 45 | Total shareowners’ equity | 15,030 | 19,154 |
| 46 | Total liabilities, redeemable noncontrolling interest and shareowners’ equity | 73,681 | 75,196 |
Cash flow statement
table #119 · current period is figure column 1| 0 | Years Ended December 31, | |||
| 1 | 2025 | 2024 | 2023 | |
| 2 | (Dollars in millions) | |||
| 3 | Cash flows from operating activities | |||
| 4 | Net income | 4,772 | 5,740 | 5,672 |
| 5 | Less: Net income from discontinued operations | 304 | 745 | 743 |
| 6 | Net income from continuing operations | 4,468 | 4,995 | 4,929 |
| 7 | Adjustments to reconcile net income from continuing operations to net cash provided by operating activities | |||
| 8 | Depreciation | 546 | 493 | 490 |
| 9 | Amortization | 842 | 659 | 514 |
| 10 | Loss (gain) on sale of non-strategic businesses and assets | 18 | 1 | (5) |
| 11 | Impairment of goodwill | 724 | - | - |
| 12 | Impairment of assets held for sale | 270 | 219 | - |
| 13 | Repositioning and other (gains) charges | (167) | 239 | 844 |
| 14 | Net payments for repositioning and other charges | (378) | (470) | (445) |
| 15 | NARCO Buyout payment | - | - | (1,325) |
| 16 | Resideo indemnification and reimbursement agreement termination payment | 1,590 | - | - |
| 17 | Asbestos liabilities divestiture payment | (1,428) | - | - |
| 18 | Pension and other postretirement income | (396) | (477) | (408) |
| 19 | Pension and other postretirement benefit payments | (20) | (32) | (35) |
| 20 | Stock compensation expense | 196 | 189 | 197 |
| 21 | Deferred income taxes | 18 | (229) | 189 |
| 22 | Other | 144 | (191) | (534) |
| 23 | Changes in assets and liabilities, net of the effects of acquisitions and divestitures | |||
| 24 | Accounts receivable | (825) | (129) | 67 |
| 25 | Inventories | (636) | (286) | (549) |
| 26 | Other current assets | (233) | (111) | 224 |
| 27 | Accounts payable | 724 | 78 | 444 |
| 28 | Accrued liabilities | 1,325 | 233 | 270 |
| 29 | Income taxes | (707) | (69) | (408) |
| 30 | Net cash provided by operating activities from continuing operations | 6,075 | 5,112 | 4,459 |
| 31 | Net cash provided by operating activities from discontinued operations | 333 | 985 | 881 |
| 32 | Net cash provided by operating activities← Net cash from operating activities | 6,408 | 6,097 | 5,340 |
| 33 | Cash flows from investing activities | |||
| 34 | Capital expenditures | (986) | (871) | (741) |
| 35 | Proceeds from disposals of property, plant and equipment | 31 | - | 43 |
| 36 | Increase in investments | (1,503) | (1,077) | (560) |
| 37 | Decrease in investments | 1,469 | 870 | 971 |
| 38 | (Payments) receipts from settlements of derivative contracts | (399) | 94 | 6 |
| 39 | Cash paid for acquisitions, net of cash acquired | (2,211) | (8,880) | (718) |
| 40 | Proceeds from sales of businesses, net of fees paid | 1,157 | - | 4 |
| 41 | Net cash used for investing activities from continuing operations | (2,442) | (9,864) | (995) |
| 42 | Net cash used for investing activities from discontinued operations | (269) | (293) | (298) |
| 43 | Net cash used for investing activities← Net cash from investing activities | (2,711) | (10,157) | (1,293) |
| 44 | Years Ended December 31, | |||
| 45 | 2025 | 2024 | 2023 | |
| 46 | (Dollars in millions) | |||
| 47 | Cash flows from financing activities | |||
| 48 | Proceeds from issuance of commercial paper and other short-term borrowings | 24,297 | 13,838 | 12,991 |
| 49 | Payments of commercial paper and other short-term borrowings | (22,815) | (11,578) | (13,663) |
| 50 | Proceeds from issuance of common stock | 237 | 537 | 196 |
| 51 | Proceeds from issuance of long-term debt | 4,035 | 10,408 | 2,986 |
| 52 | Payments of long-term debt | (2,909) | (1,812) | (1,731) |
| 53 | Repurchases of common stock | (3,804) | (1,655) | (3,715) |
| 54 | Cash dividends paid | (2,976) | (2,902) | (2,855) |
| 55 | Pre-separation funding | 1,962 | - | - |
| 56 | Spin-off cash | (449) | - | - |
| 57 | Other | 469 | 3 | 28 |
| 58 | Net cash (used for) provided by financing activities← Net cash from financing activities | (1,953) | 6,839 | (5,763) |
| 59 | Effect of foreign exchange rate changes on cash and cash equivalents | 176 | (137) | 14 |
| 60 | Net increase (decrease) in cash and cash equivalents | 1,920 | 2,642 | (1,702) |
| 61 | Cash and cash equivalents at beginning of period | 10,567 | 7,925 | 9,627 |
| 62 | Cash and cash equivalents at end of period | 12,487 | 10,567 | 7,925 |